Warfarin Concept

subject area of

• "Therapeutic range" for oral anticoagulant therapy.  Academic Article
• d-Dimer Testing to Determine the Duration of Anticoagulation Therapy  Academic Article
• A Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve Replacement  Academic Article
• A Comparison of Lyophilized Artificially Depleted Plasmas and Lyophilized Plasmas From Patients Receiving Warfarin in Correcting for Coagulometer Effects on International Normalized Ratios  Academic Article
• A Comparison of Subcutaneous Low-Molecular-Weight Heparin with Warfarin Sodium for Prophylaxis against Deep-Vein Thrombosis after Hip or Knee Implantation  Academic Article
• A Comparison of Three Months of Anticoagulation with Extended Anticoagulation for a First Episode of Idiopathic Venous Thromboembolism  Academic Article
• A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome  Academic Article
• A Computer Generated Induction System for Hospitalized Patients Starting on Oral Anticoagulant Therapy  Academic Article
• A National Survey of Canadian Practice Patterns of Warfarin After Anterior Wall Myocardial Infarction in the Current Era of Dual Antiplatelet Therapy  Academic Article
• A New, Simplified Measure of Anticoagulation Control With Warfarin: Potential Role in the Direct Oral Anticoagulant Era  Academic Article
• A Population-Based Assessment of the Drug Interaction Between Levothyroxine and Warfarin  Academic Article
• A Randomized Comparison of a Computer-Based Dosing Program with a Manual System to Monitor Oral Anticoagulant Therapy  Academic Article
• A Randomized Trial Comparing 5-mg and 10-mg Warfarin Loading Doses  Academic Article
• A Replacement for Warfarin  Academic Article
• A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score  Academic Article
• A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: The Randomized, phase II study to Evaluate the sAfety and pharmacokinetics of oraL dabIGatran etexilate in patients after heart valve replacemeNt (RE-ALIGN)  Academic Article
• A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system  Academic Article
• A cost-effectiveness analysis of alternative approaches for long-term treatment of proximal venous thrombosis  Academic Article
• A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation  Academic Article
• A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program  Academic Article
• A multicentre randomised clinical endpoint study of parma 5 computer-assisted oral anticoagulant dosage  Academic Article
• A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study  Academic Article
• A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery  Academic Article
• A randomised, double blind comparison of tecarfarin, a novel vitamin K antagonist, with warfarin  Academic Article
• A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip  Academic Article
• A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE I  Academic Article
• A review of the oral direct thrombin inhibitor ximelagatran  Academic Article
• A team-based approach to warfarin management in long term care: A feasibility study of the MEDeINR electronic decision support system  Academic Article
• ANTICOAGULANTS AFTER OPEN‐HEART SURGERY  Academic Article
• AUSTRALIAN MULTICENTRE TRIAL OF STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION  Academic Article
• Accuracy of a Portable International Normalization Ratio Monitor in Outpatients Receiving Long-Term Oral Anticoagulant Therapy  Academic Article
• Acquired hemophilia masked by warfarin therapy  Academic Article
• Activated protein C resistance, factor V Leiden and peripheral vascular disease.  Academic Article
• Additional Events in the RE-LY Trial  Academic Article
• Adjusted Subcutaneous Heparin versus Warfarin Sodium in the Long-Term Treatment of Venous Thrombosis  Academic Article
• Advances in the management of venous thromboembolism.  Academic Article
• Advances in treatment and management  Academic Article
• After PCI with stents for AF, adding rivaroxaban vs warfarin to antiplatelet drugs reduced bleeding  Academic Article
• Alcohol consumption and risk of cardiovascular outcomes and bleeding in patients with established atrial fibrillation  Academic Article
• American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy  Academic Article
• American Heart Association/American College of Cardiology Foundation guide to warfarin therapy11The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.This statement has been co-published in the April 1, 2003, issue of Circulation.This statement was approved by the American Heart Association Science Advisory and Coordinating Committee in October 2002 and by the American College of Cardiology Board of Trustees in February 2003. A single reprint is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Ave, Dallas, TX 75231-4596. Ask for reprint No. 71-0254. To purchase additional reprints: up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 410-528-4426, fax 410-528-4264, or e-mail klbradle@lww.com. To make photocopies for personal or educational use, call the Copyright Clearance Center, 978-750-8400.  Academic Article
• An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial  Academic Article
• Analysis of Warfarin Therapy in Pediatric Patients: A Prospective Cohort Study of 319 Patients  Academic Article
• Angina (unstable).  Academic Article
• Angina (unstable).  Academic Article
• Angina (unstable).  Academic Article
• Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation  Academic Article
• Another Dimension of Safety in the Prescription of Anticoagulants for Nonvalvular Atrial Fibrillation  Academic Article
• Anti-Xa effect of a low molecular weight heparin (dalteparin) does not accumulate in extended duration therapy for venous thromboembolism in cancer patients  Academic Article
• Anticoagulant therapy for the thrombotic complications of the antiphospholipid antibody syndrome  Conference Paper
• Anticoagulant-Related Nephropathy  Academic Article
• Anticoagulants During Pregnancy  Academic Article
• Anticoagulants and Their Reversal  Academic Article
• Anticoagulants in Patients with Atrial Fibrillation and End-Stage Renal Disease  Academic Article
• Anticoagulation Therapy  Academic Article
• Anticoagulation Therapy in Children  Academic Article
• Anticoagulation and Bleeding: A Pooled Analysis of Lung Cancer Trials of the NCIC Clinical Trials Group  Academic Article
• Anticoagulation for Mechanical Heart Valves  Academic Article
• Anticoagulation for Stroke Prevention in Patients With Atrial Fibrillation and End-Stage Renal Disease—First, Do No Harm  Academic Article
• Anticoagulation for pregnant women with mechanical heart valves: a systematic review and meta-analysis  Academic Article
• Anticoagulation for stroke prevention in new atrial fibrillation after coronary artery bypass graft surgery  Academic Article
• Anticoagulation of Pregnant Women With Mechanical Heart Valves  Academic Article
• Anticoagulation therapy in neonates, children and adolescents  Academic Article
• Anticoagulation therapy in patients with prosthetic heart valves.  Academic Article
• Anticoagulation therapy in the antiphospholipid syndrome: recent advances  Academic Article
• Antiphospholipid antibodies and venous thromboembolism  Academic Article
• Antiphospholipid antibody syndrome  Academic Article
• Antiphospholipid antibody syndrome: further evidence to guide clinical practice?  Academic Article
• Antiphospholipid antibody syndrome: recent findings on managing this challenging condition.  Academic Article
• Antithrombotic Activity of the Novel Oral Anticoagulant, Tecarfarin [Sodium 3-[4-((1,1,1,3,3,3-hexafluoro-2-methylpropan-2-yloxy) carbonyl) benzyl]-2-oxo-2H-chromen-4-olate] in Animal Models  Academic Article
• Antithrombotic drug development for atrial fibrillation: Proceedings, Washington, DC, July 25-27, 2005  Academic Article
• Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves  Academic Article
• Antithrombotic therapy in atrial fibrillation.  Academic Article
• Antithrombotic therapy. Introduction.  Academic Article
• Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and End-Stage Renal Disease: Lessons Learned  Academic Article
• Approach to the new oral anticoagulants in family practice: part 1: comparing the options.  Academic Article
• Appropriate Use of Antithrombotic Medication in Canadian Patients With Nonvalvular Atrial Fibrillation  Academic Article
• Are Brand-Name and Generic Warfarin Interchangeable? Multiple N-of-1 Randomized, Crossover Trials  Academic Article
• Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physicians.  Academic Article
• Are older patients with mechanical heart valves at increased risk?  Academic Article
• Aspirin  Academic Article
• Aspirin for the Prevention of Recurrent Venous Thromboembolism  Academic Article
• Assessing health literacy to identify patients for pharmacist-provided counseling on high-risk medications  Academic Article
• Assessing the impact of dabigatran and warfarin on health-related quality of life: Results from an RE-LY sub-study  Academic Article
• Assessment of Anticoagulation Intensity and Management of Bleeding With Old and New Oral Anticoagulants  Academic Article
• Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta‐analysis  Academic Article
• Atrial Fibrillation and PCI — Do We Still Need Aspirin?  Academic Article
• Atrial fibrillation in a primary care practice: prevalence and management  Academic Article
• Atrial mass in a pregnant patient with antiphospholipid antibody syndrome  Academic Article
• Azathioprine and inhibition of the anticoagulant effect of warfarin: Evidence from a case report and a literature review  Academic Article
• Balancing the Benefits and Risks of 2 Doses of Dabigatran Compared With Warfarin in Atrial Fibrillation  Academic Article
• Barriers and facilitators to optimal oral anticoagulant management: a scoping review  Academic Article
• Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa)  Academic Article
• Beyond Unfractionated Heparin and Warfarin  Academic Article
• Beyond heparin and warfarin: the new generation of anticoagulants  Academic Article
• Bivariate evaluation of thromboembolism and bleeding in clinical trials of anticoagulants in patients with atrial fibrillation  Academic Article
• Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin  Academic Article
• Bleeding events with dabigatran or warfarin in patients with venous thromboembolism  Academic Article
• Bleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin: A retrospective population-based cohort study  Academic Article
• Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta‐analysis  Academic Article
• Bleeding with Direct Oral Anticoagulants vs Warfarin: Clinical Experience  Academic Article
• Bleeding with direct oral anticoagulants vs warfarin: clinical experience  Academic Article
• Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive Procedures  Academic Article
• Bone marrow biopsy morbidity and mortality: 2002 data.  Academic Article
• Brand Name versus Generic Warfarin: A Systematic Review of the Literature  Academic Article
• Bridge Therapy Outcomes in Patients With Mechanical Heart Valves  Academic Article
• Bridge or continue Coumadin for device surgery: a randomized controlled trial rationale and design  Academic Article
• Bridging Anticoagulation  Academic Article
• Bridging anticoagulation for interruption of warfarin in a patient with atrial fibrillation  Academic Article
• Bridging anticoagulation with low-molecular-weight heparin after interruption of warfarin therapy is associated with a residual anticoagulant effect prior to surgery  Academic Article
• Brief Communication: Preoperative Anticoagulant Activity after Bridging Low-Molecular-Weight Heparin for Temporary Interruption of Warfarin  Academic Article
• Can We Predict Individual Combined Benefit and Harm of Therapy? Warfarin Therapy for Atrial Fibrillation as a Test Case  Academic Article
• Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter  Academic Article
• Canadian atrial fibrillation anticoaguiation (CAFA) study  Academic Article
• Canadian atrial fibrillation anticoagulation study: were the patients subsequently treated with warfarin? Canadian Atrial Fibrillation Anticoagulation Study Group.  Academic Article
• Cardiac Tamponade During Uninterrupted Oral Anticoagulant Therapy for Catheter Ablation for Atrial Fibrillation  Academic Article
• Cardiovascular Outcomes According to Polypharmacy and Drug Adherence in Patients with Atrial Fibrillation on Long-Term Anticoagulation (from the RE-LY Trial)  Academic Article
• Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: data from the RE-LY trial  Academic Article
• Care of Patients Receiving Long-Term Anticoagulant Therapy  Academic Article
• Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention  Academic Article
• Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF  Academic Article
• Causes of Death and Influencing Factors in Patients With Atrial Fibrillation  Academic Article
• Cerebral amyloid angiopathy, cerebral microbleeds and implications for anticoagulation decisions: The need for a balanced approach  Academic Article
• Challenges of Establishing New Antithrombotic Therapies in Atrial Fibrillation  Academic Article
• Changes in Renal Function in Patients With Atrial Fibrillation  Academic Article
• Changing Paradigms in the Management of Venous Thromboembolism  Academic Article
• Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial  Academic Article
• Cimetidine potentiation of warfarin action.  Academic Article
• Clinical Experience with Anticoagulant Therapy During Pregnancy  Academic Article
• Clinical Trials That Have Influenced the Treatment of Venous Thromboembolism: A Historical Perspective  Academic Article
• Clinical benefits of pharmacogenetic algorithm-based warfarin dosing: Meta-analysis of randomized controlled trials: Comment  Academic Article
• Clinical factors influencing the sensitivity to warfarin when restarted after surgery  Academic Article
• Clinical outcomes with unfractionated heparin or low‐molecular‐weight heparin as bridging therapy in patients on long‐term oral anticoagulants: the REGIMEN registry  Academic Article
• Clinical presentation and course of bleeding events in patients with venous thromboembolism, treated with apixaban or enoxaparin and warfarin  Academic Article
• Cluster randomized controlled trial of a simple warfarin maintenance dosing algorithm versus usual care among primary care practices  Academic Article
• Coagulation Assays  Academic Article
• Combination warfarin-ASA therapy: Which patients should receive it, which patients should not, and why?  Academic Article
• Combined warfarin–aspirin therapy: what is the evidence for benefit and harm and which patients should (and should not) receive it?  Academic Article
• Comment: Treatment of Heparin-Induced Thrombocytopenia  Academic Article
• Comments on the Important Drug Interaction of Warfarin and Sulfamethoxazole  Academic Article
• Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study  Academic Article
• Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation in real-world practice: a population-based cohort study protocol  Academic Article
• Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation: A retrospective cohort study  Academic Article
• Comparative safety of direct oral anticoagulants and warfarin in venous thromboembolism: multicentre, population based, observational study  Academic Article
• Comparing mortality in patients with atrial fibrillation who are receiving a direct‐acting oral anticoagulant or warfarin: a meta‐analysis of randomized trials  Academic Article
• Comparison Between Currently Recommended Long-Term Medical Management of Coronary Artery Aneurysms After Kawasaki Disease and Actual Reported Management in the Last Two Decades  Academic Article
• Comparison Of The Relative Efficacy And Safety Of Low Molecular Weight Heparin And Unfractionated Heparin For The Treatment Of Venous Thrombosis  Conference Paper
• Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor  Academic Article
• Comparison of 5-mg and 10-mg Loading Doses in Initiation of Warfarin Therapy  Academic Article
• Comparison of Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Ximelagatran or Warfarin  Academic Article
• Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive Patients With Atrial Fibrillation (from the RE-LY Trial)  Academic Article
• Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease  Academic Article
• Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism  Academic Article
• Comparison of a daily fixed 2.5-mg warfarin dose with a 5-mg, international normalized ratio adjusted, warfarin dose initially following heart valve replacement  Academic Article
• Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial  Academic Article
• Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial  Academic Article
• Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists  Academic Article
• Comparison of pain and ecchymosis with low-molecular-weight heparin vs. unfractionated heparin in patients requiring bridging anticoagulation after warfarin interruption: a randomized trial  Academic Article
• Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials  Academic Article
• Comparison of treatment effect estimates of non-vitamin K antagonist oral anticoagulants versus warfarin between observational studies using propensity score methods and randomized controlled trials  Academic Article
• Complications of long-term anticoagulation  Academic Article
• Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients With Atrial Fibrillation  Academic Article
• Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial  Academic Article
• Consensus Document: Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting  Academic Article
• Considerations when prescribing trimethoprim-sulfamethoxazole  Academic Article
• Contra: “Bridging anticoagulation is needed during warfarin interruption when patients require elective surgery”  Academic Article
• Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery.  Academic Article
• Cost Effectiveness of Continued-Warfarin Versus Heparin-Bridging Therapy During Pacemaker and Defibrillator Surgery  Academic Article
• Cost effectiveness of LAA closure in patients with AF and contraindications to warfarin: comment  Academic Article
• Cost-effectiveness analysis of dabigatran and anticoagulation monitoring strategies of vitamin K antagonist  Academic Article
• Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation  Academic Article
• Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: A Canadian payer perspective  Academic Article
• Cost-effectiveness of enoxaparin versus warfarin prophylaxis against deep-vein thrombosis after total hip replacement.  Academic Article
• Current agents for the treatment of patients with heparin-induced thrombocytopenia  Academic Article
• D-dimer and factor VIIa in atrial fibrillation – prognostic values for cardiovascular events and effects of anticoagulation therapy  Academic Article
• Dabigatran Versus Warfarin  Academic Article
• Dabigatran Versus Warfarin in Patients With Atrial Fibrillation  Academic Article
• Dabigatran and Warfarin in Vitamin K Antagonist–Naive and –Experienced Cohorts With Atrial Fibrillation  Academic Article
• Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction?  Academic Article
• Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial  Academic Article
• Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: a subgroup analysis of the RE‐LY trial  Academic Article
• Dabigatran etexilate and reduction in serum apolipoprotein B  Academic Article
• Dabigatran for stroke prevention in atrial fibrillation: the RE-LY trial  Academic Article
• Dabigatran in Patients with Mechanical Heart Valves  Academic Article
• Dabigatran in clinical practice: Contemporary overview of the evidence  Academic Article
• Dabigatran is Less Effective Than Warfarin at Attenuating Mechanical Heart Valve‐Induced Thrombin Generation  Academic Article
• Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II.  Academic Article
• Dabigatran versus Warfarin for Venous Thromboembolism  Academic Article
• Dabigatran versus Warfarin in Patients with Atrial Fibrillation  Academic Article
• Dabigatran versus Warfarin in Patients with Mechanical Heart Valves  Academic Article
• Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism  Academic Article
• Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada  Academic Article
• Dabigatran versus warfarin in patients with mechanical heart valves: reply  Academic Article
• Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation— the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study  Academic Article
• Dalteparin versus Warfarin for the Prevention of Recurrent Venous Thromboembolic Events in Cancer Patients  Academic Article
• Decreasing warfarin sensitivity during the first three months after heart valve surgery: Implications for dosing  Academic Article
• Deep Vein Thrombosis: Recovery or Recurrence?  Academic Article
• Deep vein thrombosis  Academic Article
• Deep venous thrombosis as a cause of stump swelling in two lower extremity amputee patients.  Academic Article
• Delayed intracranial hemorrhage after head injury among elderly patients on anticoagulation seen in the emergency department  Academic Article
• Delivery of Optimized Anticoagulant Therapy: Consensus Statement from the Anticoagulation Forum  Academic Article
• Dental surgery for patients on anticoagulant therapy with warfarin: a systematic review and meta-analysis.  Academic Article
• Design, Progress and Challenges of a Double-Blind Trial of Warfarin versus Aspirin for Symptomatic Intracranial Arterial Stenosis  Academic Article
• Device Surgery without Interruption of Anticoagulation  Academic Article
• Device surgery without interruption of anticoagulation.  Academic Article
• Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study Commentary: Varied preferences reflect the reality of clinical practice  Academic Article
• Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis  Academic Article
• Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding  Academic Article
• Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients Undergoing Cardioversion for Atrial Fibrillation: a Systematic Review and Meta-analysis  Academic Article
• Direct and indirect costs of management of long‐term warfarin therapy in Canada  Academic Article
• Does Celecoxib Potentiate the Anticoagulant Effect of Warfarin? A Randomized, Double-Blind, Controlled Trial  Academic Article
• Does Statin Therapy Decrease the Risk for Bleeding in Patients Who Are Receiving Warfarin?  Academic Article
• Does acetylsalicylic acid or warfarin affect the accuracy of fecal occult blood tests?  Academic Article
• Dose reduction of edoxaban preserves efficacy and safety for the treatment of venous thromboembolism  Academic Article
• Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer  Academic Article
• Dual and triple antithrombotic therapies: current patterns of practice and controversies  Academic Article
• Duration of anticoagulants in acute or recurrent venous thromboembolism  Academic Article
• EXPERIMENTAL PRODUCTION OF MICROANGIOPATHIC HÆMOLYTIC ANÆMIA IN VIVO  Academic Article
• Early time courses of recurrent thromboembolism and bleeding during apixaban or enoxaparin/warfarin therapy  Academic Article
• Edoxaban and amiodarone: interactions on multiple levels  Academic Article
• Edoxaban versus Warfarin in Patients with Atrial Fibrillation  Academic Article
• Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial  Academic Article
• Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect  Academic Article
• Effect of Aspirin and warfarin therapy on thromboembolic events in patients with univentricular hearts and Fontan palliation  Academic Article
• Effect of Direct Oral Anticoagulants, Warfarin, and Antiplatelet Agents on Risk of Device Pocket Hematoma  Academic Article
• Effect of Warfarin on Activated Partial Thromboplastin Time in Patients Receiving Heparin  Academic Article
• Effect of a simple two‐step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study  Academic Article
• Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes  Academic Article
• Effectiveness and Safety of Rivaroxaban Versus Warfarin in Frail Patients with Venous Thromboembolism  Academic Article
• Effectiveness and outcome of management strategies for dabigatran- or warfarin-related major bleeding events  Academic Article
• Effectiveness and safety among direct oral anticoagulants in nonvalvular atrial fibrillation: A multi‐database cohort study with meta‐analysis  Academic Article
• Effectiveness and safety of direct oral anticoagulants in patients with venous thromboembolism and creatinine clearance < 30 mL/min  Academic Article
• Effectiveness and safety of outpatient rivaroxaban versus warfarin for treatment of venous thromboembolism in patients with a known primary hypercoagulable state  Academic Article
• Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism  Academic Article
• Effectiveness and safety of rivaroxaban versus warfarin in patients with provoked venous thromboembolism  Academic Article
• Effectiveness and safety of rivaroxaban vs. warfarin in non-valvular atrial fibrillation patients with a non-sex-related CHA2DS2-VASc score of 1  Academic Article
• Effects of sodium warfarin administered during pregnancy in mice  Academic Article
• Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation  Academic Article
• Efficacy and Safety of Dabigatran Compared to Warfarin in Patients With Paroxysmal, Persistent, and Permanent Atrial Fibrillation  Academic Article
• Efficacy and Safety of Dabigatran Etexilate vs. Warfarin in Asian RE-LY Patients According to Baseline Renal Function or CHADS₂ Score  Academic Article
• Efficacy and Safety of Dabigatran vs. Warfarin in Patients With Atrial Fibrillation - Sub-Analysis in Japanese Population in RE-LY Trial -  Academic Article
• Efficacy and Safety of Warfarin VS. Antiplatelet Therapy in Patients with Systolic Heart Failure and Sinus Rhythm: A Systematic Review and Meta-Analysis of Randomized Controlled Trials  Academic Article
• Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial  Academic Article
• Efficacy and safety of dabigatran compared with warfarin in patients with atrial fibrillation in relation to renal function over time—A RE-LY trial analysis  Academic Article
• Efficacy and safety of early parenteral anticoagulation as a bridge to warfarin after mechanical valve replacement  Academic Article
• Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER^®, RE-COVER™ II, and RE-MEDY™  Academic Article
• Emerging anticoagulants for the treatment of venous thromboembolism  Academic Article
• Epidural Catheter Use and Further Issues in Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant—Reply  Academic Article
• Establishing an Optimal Therapeutic Range for Coumarins  Academic Article
• Evaluation of an initiation protocol of 4 mg of warfarin for atrial fibrillation in the outpatient setting.  Academic Article
• Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials  Academic Article
• Evaluation of the phospholipid-rich dilute Russell's viper venom assay to monitor oral anticoagulation in patients with lupus anticoagulant.  Academic Article
• Evidence based treatment of the antiphospholipid syndromeII. Optimal anticoagulant therapy for thrombosis  Academic Article
• Evidence for the Needs of Out-of-Hospital Thrombosis Prophylaxis  Academic Article
• Exaggerated initial response to warfarin following heart valve replacement  Academic Article
• Examining therapeutic equivalence between branded and generic warfarin in Brazil: The WARFA crossover randomized controlled trial  Academic Article
• Exercise-Induced Deep Vein Thrombosis of the Upper Extremity  Academic Article
• Extended Anticoagulation in Venous Thromboembolism  Academic Article
• Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism  Academic Article
• Extended anticoagulant therapy in venous thromboembolism: a balanced, fractional factorial, clinical vignette-based study  Academic Article
• Extended anticoagulation in venous thromboembolism.  Academic Article
• Extended anticoagulation in venous thromboembolism.  Academic Article
• Extended anticoagulation in venous thromboembolism.  Academic Article
• Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study  Academic Article
• Factors predicting reoperation of chronic subdural hematoma following primary surgical evacuation  Academic Article
• Failure to correct International Normalized Ratio and mortality among patients with warfarin‐related major bleeding: an analysis of electronic health records  Academic Article
• Fatal heparin‐induced thrombocytopenia (HIT) during warfarin thromboprophylaxis following orthopedic surgery: another example of ‘spontaneous’ HIT?  Academic Article
• Fetal Effects of Coumadin Administered During Pregnancy  Academic Article
• Fetal and neonatal outcome of exposure to anticoagulants during pregnancy  Academic Article
• Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT) – Bridging the River Coumarin  Academic Article
• Gastrointestinal Bleeding With Edoxaban Versus Warfarin  Academic Article
• Gastrointestinal bleeding with the new oral anticoagulants – defining the issues and the management strategies  Academic Article
• Genetic determinants of warfarin maintenance dose and time in therapeutic treatment range: a RE-LY genomics substudy  Academic Article
• Guide to anticoagulant therapy. Part 2: Oral anticoagulants. American Heart Association.  Academic Article
• HIT complicating fondaparinux prophylaxis: fondaparinux-dependent platelet activation as a marker for fondaparinux- induced HIT  Academic Article
• Has the incidence of deep vein thrombosis in patients undergoing total hip/knee arthroplasty changed over time? A systematic review of randomized controlled trials  Academic Article
• Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding  Academic Article
• Heart failure.  Academic Article
• Heart failure.  Academic Article
• Heart failure.  Academic Article
• Heparin for 5 Days as Compared with 10 Days in the Initial Treatment of Proximal Venous Thrombosis  Academic Article
• Heparin-Induced Thrombocytopenia  Academic Article
• Heparin-Induced Thrombocytopenia  Academic Article
• Heparin-Induced Thrombocytopenia: A Ten-Year Retrospective  Academic Article
• Heparin-Induced thrombocytopenia: IgG-Mediated platelet activation, platelet microparticle generation, and altered procoagulant/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-Induced thrombocytopenia  Academic Article
• Heparin-induced thrombocytopenia and its treatment.  Conference Paper
• Heparin‐induced thrombocytopenia (HIT) during postoperative warfarin thromboprophylaxis: a second example of postorthopedic surgery ‘spontaneous’ HIT  Academic Article
• Higher-risk APS: do we dare to DOAC?  Academic Article
• Home prophylactic warfarin anticoagulation program after hip and knee arthroplasty.  Academic Article
• Home-monitoring of oral anticoagulation vs. dabigatran  Academic Article
• Hospitalization for Hemorrhage Among Warfarin Recipients Prescribed Amiodarone  Academic Article
• How I manage anticoagulant therapy in older individuals with atrial fibrillation or venous thromboembolism  Academic Article
• How I treat anticoagulated patients undergoing an elective procedure or surgery  Academic Article
• How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch  Academic Article
• How Should Results from Completed Studies Influence Ongoing Clinical Trials?  Academic Article
• Hypercoagulable state and thromboembolism following warfarin withdrawal in post-myocardial-infarction patients  Academic Article
• INTERACTION OF IBUPROFEN AND WARFARIN ON PRIMARY HAEMOSTASIS  Academic Article
• Idrabiotaparinux treatment for venous thromboembolism  Academic Article
• Impact of Body Mass Index and Genetics on Warfarin Major Bleeding Outcomes in a Community Setting  Academic Article
• Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF‐TIMI 48 Trial  Academic Article
• In AF, apixaban reduced stroke or systemic embolism compared with warfarin, regardless of patient age  Academic Article
• Inadequate monitoring of warfarin dosage [letter] [see comments]  Academic Article
• Incidence and predictors of bleeding or thrombosis after polypectomy in patients receiving and not receiving anticoagulation therapy  Academic Article
• Incidence and risk factors for acute kidney injury in patients with excessive anticoagulation on warfarin: a retrospective study  Academic Article
• Incidence of Cancer after Prophylaxis with Warfarin against Recurrent Venous Thromboembolism  Academic Article
• Incidence of Direct Oral Anticoagulant Prescriptions in Kidney Transplant Recipients in Ontario, Canada  Academic Article
• Incorporating edoxaban into the choice of anticoagulants for atrial fibrillation  Academic Article
• Increased thrombin generation and activity in patients with systemic lupus erythematosus and anticardiolipin antibodies: evidence for a prothrombotic state [see comments]  Academic Article
• Indirect comparison: relative risk fallacies and odds solution  Academic Article
• Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale  Academic Article
• Individual Treatment Effect Estimation of 2 Doses of Dabigatran on Stroke and Major Bleeding in Atrial Fibrillation  Academic Article
• Influence of Warfarin on Symptoms of Fatigue: Findings of a Randomized Trial  Academic Article
• Influence of low-intensity warfarin treatment on patients' perceptions of quality of life  Academic Article
• Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial  Academic Article
• Influenza Vaccination and Vitamin K Antagonist Treatment  Academic Article
• Inhibition of Warfarin Activity by Ribavirin  Academic Article
• Integrating Frailty Assessment Into Cardiovascular Decision Making  Academic Article
• Intensity and Quality of Warfarin Anticoagulation in Chinese Patients  Academic Article
• Intensity of Warfarin Coagulation in the Antiphospholipid Syndrome  Academic Article
• Intensive Initial Oral Anticoagulation and Shorter Heparin Treatment in Deep Vein Thrombosis  Academic Article
• Interactions of Warfarin with Drugs and Food  Academic Article
• Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation  Academic Article
• Intracranial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation With Warfarin or Dabigatran  Academic Article
• Intracranial bleeding: epidemiology and relationships with antithrombotic treatment in 241 cerebral hemorrhages in Reggio Emilia.  Academic Article
• Is It Time to Systematically Replace Warfarin With a New Oral Anticoagulant for Higher-Risk Patients With Nonvalvular Atrial Fibrillation?  Academic Article
• Is the dose of warfarin prescribed by American physicians unnecessarily high?  Academic Article
• Is the warfarin saga over?  Academic Article
• Is there really misuse and abuse of dabigatran?  Academic Article
• Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48  Academic Article
• Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation  Academic Article
• Laboratory Monitoring of Non–Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation  Academic Article
• Left Atrial Appendage Occlusion Does Not Eliminate the Need for Warfarin  Academic Article
• Left Atrial Appendage Occlusion Eliminates the Need for Warfarin  Academic Article
• Limitations of conventional treatment options for heparin-induced thrombocytopenia.  Academic Article
• Loading dose vs. maintenance dose of warfarin for reinitiation after invasive procedures: a randomized trial  Academic Article
• Locations and Mucosal Lesions Responsible for Major Gastrointestinal Bleeding in Patients on Warfarin or Dabigatran  Academic Article
• Long-Term Oral Anticoagulant Therapy in Patients With Unstable Angina or Suspected Non–Q-Wave Myocardial Infarction  Academic Article
• Long-Term Prophylaxis in Venous Thromboembolism: LMWH or Oral Anticoagulation?  Conference Paper
• Long-term evaluation of dabigatran 150 vs. 110 mg twice a day in patients with non-valvular atrial fibrillation  Academic Article
• Long-term occurrence of death and cardiovascular events in patients with transient ischaemic attack or minor ischaemic stroke: comparison between arterial and cardiac source of the index event  Academic Article
• Long‐duration therapy with low molecular weight heparin in patients with antiphospholipid antibody syndrome resistant to warfarin therapy  Academic Article
• Long‐term management of venous thromboembolism: is there a role for low‐intensity warfarin therapy?  Academic Article
• Low-Intensity Adjusted-Dose Warfarin for the Prevention of Hemodialysis Catheter Failure  Academic Article
• Low-Intensity Warfarin Is Ineffective for the Prevention of PTFE Graft Failure in Patients on Hemodialysis  Academic Article
• Low-Intensity versus Conventional-Intensity Warfarin for Prevention of Recurrent Venous Thromboembolism  Academic Article
• Low-Molecular-Weight Heparin Prophylaxis Using Dalteparin in Close Proximity to Surgery vs Warfarin in Hip Arthroplasty Patients  Academic Article
• Low-Molecular-Weight Heparin as Bridging Anticoagulation During Interruption of Warfarin  Academic Article
• Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer  Academic Article
• Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial  Academic Article
• Low-dose Oral Vitamin K Reliably Reverses Over-anticoagulation due to Warfarin  Academic Article
• Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10  Academic Article
• Low-dose oral vitamin K therapy for the management of asymptomatic patients with elevated international normalized ratios: a brief review  Academic Article
• Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin  Academic Article
• Low-dose warfarin in rehabilitating stroke survivors  Academic Article
• Lower versus Standard INR Targets in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials  Academic Article
• Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study  Academic Article
• Major Gastrointestinal Bleeding Often Is Caused by Occult Malignancy in Patients Receiving Warfarin or Dabigatran to Prevent Stroke and Systemic Embolism From Atrial Fibrillation  Academic Article
• Major bleeding risk with warfarin for deep vein thrombosis.  Academic Article
• Malignancy-associated venous thrombosis with concurrent warfarin-induced skin necrosis, venous limb gangrene and thrombotic microangiopathy  Academic Article
• Management Of Venous Thromboembolism: Optimization By Clinical Trials  Academic Article
• Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin  Academic Article
• Management consensus guidance for the use of rivaroxaban – an oral, direct factor Xa inhibitor  Academic Article
• Management of Anticoagulation Around Pacemaker and Defibrillator Surgery  Academic Article
• Management of Anticoagulation before and after Elective Surgery  Academic Article
• Management of Antiphospholipid Antibody Syndrome  Academic Article
• Management of Bleeding Complications in the Anticoagulated Patient  Academic Article
• Management of bleeding complications in patients with cancer on DOACs  Academic Article
• Management of patients who are receiving warfarin or a new oral anticoagulant and require urgent or emergency surgery  Academic Article
• Management of venous thromboembolism in cancer patients.  Academic Article
• Managing New Oral Anticoagulants in the Perioperative and Intensive Care Unit Setting  Academic Article
• Mechanical left atrial appendage closure was noninferior and superior to warfarin in atrial fibrillation  Academic Article
• Mechanism of Action and Monitoring of Anticoagulants  Academic Article
• Meeting the Unmet Needs in Anticoagulant Therapy  Academic Article
• Miconazole Oral Gel Potentiates Warfarin Anticoagulant Activity  Academic Article
• Microangiopathic Haemolytic Anaemia: the Experimental Production of Haemolysis and Red-Cell Fragmentation by Defibrination in Vivo  Academic Article
• Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta‐analysis of randomized controlled trials  Academic Article
• Multicentric evaluation of heparinase on aPTT, thrombin clotting time and a new PT reagent based on recombinant human tissue factor  Academic Article
• Multicentric warfarin-induced skin necrosis complicating heparin-induced thrombocytopenia  Academic Article
• Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial  Academic Article
• Navigating the anticoagulant landscape in 2017  Academic Article
• Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: analyses from RE-COVER®, RE-COVER™ II, and RE-MEDY™  Academic Article
• New Anticoagulants  Academic Article
• New anticoagulants in atrial fibrillation management  Conference Paper
• New anticoagulants: beyond heparin, low-molecular-weight heparin and warfarin  Academic Article
• New developments in anticoagulants: Past, present and future  Academic Article
• New oral anticoagulant agents – general features and outcomes in subsets of patients  Academic Article
• New oral anticoagulants in elderly patients  Academic Article
• New oral anticoagulants: which one should my patient use?  Academic Article
• New-Onset Atrial Fibrillation  Academic Article
• Nonadherence with INR Monitoring and Anticoagulant Complications  Academic Article
• Novel Oral Anticoagulants and the Risk of Major Hemorrhage in Elderly Patients With Chronic Kidney Disease: A Nested Case-Control Study  Academic Article
• Novel oral anticoagulants in secondary prevention of stroke  Academic Article
• Optimal Duration of Oral Anticoagulant Therapy: A Randomized Trial Comparing Four Weeks with Three Months of Warfarin in Patients with Proximal Deep Vein Thrombosis  Academic Article
• Optimal Timing of Resumption of Warfarin After Intracranial Hemorrhage  Academic Article
• Optimal intensity and monitoring warfarin  Academic Article
• Optimal therapeutic level of heparin therapy in patients with venous thrombosis  Academic Article
• Oral Anticoagulant Drugs  Academic Article
• Oral Anticoagulant Initiation: Rationale for the Use of Warfarin Dosing Nomograms  Academic Article
• Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease  Academic Article
• Oral Apixaban for the Treatment of Acute Venous Thromboembolism  Academic Article
• Oral Rivaroxaban for Symptomatic Venous Thromboembolism  Academic Article
• Oral Vitamin K Lowers the International Normalized Ratio More Rapidly Than Subcutaneous Vitamin K in the Treatment of Warfarin-Associated Coagulopathy  Academic Article
• Oral Vitamin K Versus Placebo to Correct Excessive Anticoagulation in Patients Receiving Warfarin  Academic Article
• Oral anticoagulants in patients with coronary artery disease  Academic Article
• Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range  Academic Article
• Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range.  Academic Article
• Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.  Academic Article
• Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.  Academic Article
• Oral anticoagulation for prolonging survival in patients with cancer  Academic Article
• Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation  Academic Article
• Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation  Academic Article
• Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation  Academic Article
• Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation  Academic Article
• Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation  Academic Article
• Oral anticoagulation may prolong survival of a subgroup of patients with cancer: a cochrane systematic review  Academic Article
• Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial  Academic Article
• Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10  Academic Article
• Oral vitamin K for warfarin-associated coagulopathy.  Academic Article
• Oral vitamin K produces a normal INR within 24 hours of its administration in most patients discontinuing warfarin.  Academic Article
• Oral-anticoagulant-related intracerebral hemorrhage  Academic Article
• Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials  Academic Article
• Outcomes and predictors of very stable INR control during chronic anticoagulation therapy  Academic Article
• Outcomes of Temporary Interruption of Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation  Academic Article
• Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study  Academic Article
• Overview of the New Oral Anticoagulants  Academic Article
• Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation  Academic Article
• Paper-based dosing algorithms for maintenance of warfarin anticoagulation  Academic Article
• Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation  Academic Article
• Parenteral anticoagulation in ambulatory patients with cancer  Academic Article
• Parenteral anticoagulation in ambulatory patients with cancer  Academic Article
• Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation  Academic Article
• Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation  Academic Article
• Patient education about anticoagulant medication: Is narrative evidence or statistical evidence more effective?  Academic Article
• Patient outcomes using the European label for dabigatran  Academic Article
• Patient preferences for capillary vs. venous INR determination in an anticoagulation clinic: a randomized controlled trial  Academic Article
• Patient-reported health preferences of anticoagulant-related outcomes  Academic Article
• Patients' perspectives on taking warfarin: qualitative study in family practice  Academic Article
• Peri-operative Adverse Outcomes in Patients with Atrial Fibrillation Taking Warfarin or Edoxaban: Analysis of the ENGAGE AF-TIMI 48 Trial  Academic Article
• Perioperative Anticoagulation in Patients with Mechanical Heart Valves Undergoing Elective Surgery: Results of a Survey Conducted among Korean Physicians  Academic Article
• Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation  Academic Article
• Perioperative Management of Oral Anticoagulation  Academic Article
• Perioperative Management of Patients Having Noncardiac Surgery Who Are Receiving Anticoagulant or Antiplatelet Therapy: An Evidence-Based but Practical Approach  Academic Article
• Perioperative Management of Patients Receiving Anticoagulant or Antiplatelet Therapy: A Clinician-Oriented and Practical Approach  Academic Article
• Perioperative Management of Patients Receiving Oral Anticoagulants  Academic Article
• Perioperative Management of Patients Receiving Oral Anticoagulants  Academic Article
• Perioperative Management of Warfarin Therapy: To Bridge or Not to Bridge, That Is the Question  Academic Article
• Perioperative anticoagulation in patients with chronic atrial fibrillation who are undergoing elective surgery: results of a physician survey.  Academic Article
• Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians  Academic Article
• Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure  Academic Article
• Perioperative management of antithrombotic therapy  Academic Article
• Perioperative management of patients who are receiving warfarin therapy: an evidence-based and practical approach  Academic Article
• Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin  Academic Article
• Periprocedural Management of New Oral Anticoagulants in Patients Undergoing Atrial Fibrillation Ablation  Academic Article
• Periprocedural Management of Oral Anticoagulation  Academic Article
• Periprocedural Management of Oral Anticoagulation in Patients With Atrial Fibrillation: Approach in the Era of New Oral Anticoagulants  Academic Article
• Periprocedural anticoagulation practices in warfarin-treated patients who require elective angiography with or without percutaneous coronary intervention: A retrospective chart review  Academic Article
• Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery  Academic Article
• Persistence With Therapy Among Patients Treated With Warfarin for Atrial Fibrillation  Academic Article
• Pharmacogenetics of antiplatelets and anticoagulants: a report on clopidogrel, warfarin and dabigatran  Academic Article
• Pharmacokinetic Optimisation of the Treatment of Deep Vein Thrombosis  Academic Article
• Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation.  Academic Article
• Plasma versus prothrombin complex concentrate for warfarin-associated major bleeding: a systematic review  Academic Article
• Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease  Academic Article
• Possible Influence of Stroke Etiology on Hemorrhagic Transformation Following Thrombolysis in Warfarin-Treated Patients  Academic Article
• Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial  Academic Article
• Post‐thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months  Academic Article
• Practical aspects of new oral anticoagulant use in atrial fibrillation  Academic Article
• Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failure  Conference Paper
• Practical management of bleeding in patients receiving non-vitamin K antagonist oral anticoagulants  Academic Article
• Practical management of coagulopathy associated with warfarin.  Academic Article
• Praktische Behandlung der Warfarin-assoziierten Gerinnungsstörung  Academic Article
• Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy  Academic Article
• Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment  Academic Article
• Prediction of individual combined benefit and harm for patients with atrial fibrillation considering warfarin therapy: a study protocol  Academic Article
• Predictors of perioperative major bleeding in patients who interrupt warfarin for an elective surgery or procedure: Analysis of the BRIDGE trial  Academic Article
• Predictors of the post‐thrombotic syndrome during long‐term treatment of proximal deep vein thrombosis  Academic Article
• Preference-Based Antithrombotic Therapy in Atrial Fibrillation: Implications for Clinical Decision Making  Academic Article
• Pretreatment of Rabbits With Either Hirudin, Ancrod, or Warfarin Significantly Reduces the Immediate Uptake of Fibrinogen and Platelets by the Deendothelialized Aorta Wall After Balloon-Catheter Injury In Vivo  Academic Article
• Preventing Cardioembolic Stroke in Atrial Fibrillation with Dabigatran  Academic Article
• Preventing and managing bleeding complications in anticoagulated patients: A case based approach  Academic Article
• Preventing stroke in patients with atrial fibrillation: Current treatments and new concepts  Academic Article
• Prevention of Postthrombotic Syndrome  Academic Article
• Prevention of Recurrent Venous Thrombosis: Warfarin versus Heparin  Academic Article
• Prevention of Thromboembolic Events After Bioprosthetic Aortic Valve Replacement  Academic Article
• Prevention of Vascular Events in Patients with Atrial Fibrillation:  Academic Article
• Prevention of Venous Thromboembolism After Hip or Knee Arthroplasty  Academic Article
• Pro: “Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation”  Academic Article
• Profile of betrixaban and its potential in the prevention and treatment of venous thromboembolism  Academic Article
• Prognostic differences between atrial fibrillation and atrial flutter  Academic Article
• Prothrombin complex concentrate (PCC, Octaplex®) in patients requiring immediate reversal of vitamin K antagonist anticoagulation  Academic Article
• Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate  Academic Article
• Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal A systematic review and meta-analysis  Academic Article
• Pulmonary hypertension and pregnancy: a series of eight cases  Academic Article
• Quality of Anticoagulation Control in Preventing Adverse Events in Patients With Heart Failure in Sinus Rhythm  Academic Article
• Quality of anticoagulation and use of warfarin-interacting medications in long-term care: A chart review  Academic Article
• Quality of individual INR control and the risk of stroke and bleeding events in atrial fibrillation patients: A nested case control analysis of the ACTIVE W study  Academic Article
• RANDOMISED COMPARISON OF TWO INTENSITIES OF ORAL ANTICOAGULANT THERAPY AFTER TISSUE HEART VALVE REPLACEMENT  Academic Article
• Randomised comparison of a simple warfarin dosing algorithm versus a computerised anticoagulation management system for control of warfarin maintenance therapy  Academic Article
• Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation  Academic Article
• Randomized Placebo-Controlled Study of Low-Dose Warfarin for the Prevention of Central Venous Catheter–Associated Thrombosis in Patients With Cancer  Academic Article
• Randomized Trial of Warfarin Nomograms  Academic Article
• Randomized Trial of Warfarin Nomograms  Academic Article
• Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure  Academic Article
• Randomized controlled trials of new oral anticoagulants for stroke prevention in atrial fibrillation  Academic Article
• Randomized trial of warfarin nomograms.  Academic Article
• Rates of Ischemic Stroke During Warfarin Treatment for Atrial Fibrillation  Academic Article
• Rates of hemorrhage during warfarin therapy for atrial fibrillation  Academic Article
• Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment  Academic Article
• Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran  Academic Article
• Re: The Clinical Quality Improvement Network (CQIN) Investigators. Thromboembolic prophylaxis in 3,575 hospitalized patients with atrial fibrillation. 1998;14:695-702.  Academic Article
• Reasons for hospitalization and risk of mortality in patients with atrial fibrillation treated with dabigatran or warfarin in the Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trial  Academic Article
• Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis  Academic Article
• Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study  Academic Article
• Reduced-Intensity Anticoagulation for Mechanical Aortic Valve Prostheses  Academic Article
• Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: A randomized trial  Academic Article
• Reducing the risk of recurrent stroke in patients with AF  Academic Article
• Reliability of the international normalized ratio for monitoring the induction phase of warfarin: Comparison with the prothrombin time ratio  Academic Article
• Resident Physicians Choices of Anticoagulation for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation  Academic Article
• Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: The extended DACUS study  Academic Article
• Resolving Concerns With the Newer Oral Anticoagulant Medications  Academic Article
• Response to Letter Regarding Article, “Causes of Death and Influencing Factors in Patients With Atrial Fibrillation: A Competing-Risk Analysis From the Randomized Evaluation of Long-Term Anticoagulant Therapy Study”  Academic Article
• Response to Letter Regarding Article, “Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation: A RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial Analysis”  Academic Article
• Response to Letter Regarding Article, “Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin”  Academic Article
• Response to letter: non‐vitamin‐K oral anticoagulants may not significantly reduce the risk of fatal or disabling stroke compared with warfarin  Academic Article
• Response to letters regarding article, “Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”.  Academic Article
• Resuming warfarin after intracranial hemorrhage in patients with AF was linked to reduced mortality  Academic Article
• Resumption of Oral Anticoagulation After Warfarin-Associated Intracerebral Hemorrhage  Academic Article
• Resumption of Warfarin Therapy After Gastrointestinal Tract Bleeding: Benefit or Bias?—Reply  Academic Article
• Retinal vein thrombosis: The Internist's role in the etiologic and therapeutic management  Academic Article
• Reversal of Warfarin  Academic Article
• Reversal of the Anticoagulant Effects of Warfarin by Vitamin K1  Academic Article
• Reversal of vitamin K antagonist-associated coagulopathy: A survey of current practice  Academic Article
• Reversible endotension associated with excessive warfarin anticoagulation  Academic Article
• Reversing Anticoagulant Therapy  Academic Article
• Reversing anticoagulants both old and new.  Academic Article
• Risk Stratification and Stroke Prevention Therapy Care Gaps in Canadian Atrial Fibrillation Patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation Chart Audit)  Academic Article
• Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials  Academic Article
• Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation  Academic Article
• Risk of Thromboembolism, Recurrent Hemorrhage, and Death After Warfarin Therapy Interruption for Gastrointestinal Tract Bleeding  Academic Article
• Risk of post‐thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study  Academic Article
• Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage  Academic Article
• Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk  Academic Article
• Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: An exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials  Academic Article
• Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS_2 Score: A Subgroup Analysis of the RE-LY Trial  Academic Article
• Rivaroxaban for stroke prevention in atrial fibrillation: a critical review of the ROCKET AF trial  Academic Article
• Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation  Academic Article
• Role of antithrombotic therapy in atrial fibrillation.  Academic Article
• Role of oral anticoagulation in management of atrial fibrillation  Academic Article
• Role of triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents  Academic Article
• Safe bridging to warfarin in heparin-induced thrombocytopenia  Academic Article
• Safer anticoagulant therapy after heart valve replacement  Academic Article
• Safety and Efficacy of Dabigatran Compared With Warfarin for Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-analysis  Academic Article
• Safety of continuing warfarin therapy during cataract surgery: A systematic review and meta-analysis  Academic Article
• Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists  Academic Article
• Sensorineural hearing loss in systemic lupus erythematosus: case report and literature review  Academic Article
• Serial measurement of interleukin‐6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE‐LY trials  Academic Article
• Serotonin‐release assay‐positive but platelet factor 4‐dependent enzyme‐immunoassay negative: HIT or not HIT ?  Academic Article
• Setting a standard for venous thromboembolism prophylaxis  Academic Article
• Short report: managing anticoagulation. Comparison of results at three primary care centres.  Academic Article
• Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial  Academic Article
• Should Warfarin Be Restarted After Warfarin-Associated Intracranial Hemorrhage?  Academic Article
• Should vitamin K be administered when HIT is diagnosed after administration of coumarin?  Academic Article
• Side-Effects of COVID-19 on Patient Care: An INR Story  Academic Article
• Single-Arm Study of Bridging Therapy With Low-Molecular-Weight Heparin for Patients at Risk of Arterial Embolism Who Require Temporary Interruption of Warfarin  Academic Article
• Single-dose adjustment versus no adjustment of warfarin in stably anticoagulated patients with an occasional international normalized ratio (INR) out of range  Academic Article
• Small intestinal bacterial overgrowth and warfarin dose requirement variability  Academic Article
• Socioeconomic status and risk of hemorrhage during warfarin therapy for atrial fibrillation: A population-based study  Academic Article
• Solving the mystery of excessive warfarin-induced bleeding: A personal historical perspective  Academic Article
• Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trial  Academic Article
• Stroke Prenotification Is Associated with Shorter Treatment Times for Warfarin-Associated Intracerebral Hemorrhage  Academic Article
• Stroke Prevention in Atrial Fibrillation II Study  Academic Article
• Stroke Prevention in Atrial Fibrillation II Study.  Academic Article
• Stroke Prevention in Nonvalvular Atrial Fibrillation  Academic Article
• Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey  Academic Article
• Stroke prevention in atrial fibrillation: Closing the gap  Academic Article
• Structure and function of a perioperative anticoagulation management clinic  Academic Article
• Studies on the medical treatment of deep vein thrombosis.  Academic Article
• Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective  Academic Article
• Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose  Academic Article
• Substandard monitoring of warfarin in North America. Time for change  Academic Article
• Survey of cardiac surgeons' perceptions of the addition of ASA to warfarin for patients with mechanical heart valves.  Academic Article
• Systematic Overview of Warfarin and Its Drug and Food Interactions  Academic Article
• Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis  Academic Article
• Tailoring warfarin induction doses to reflect individual and disease-specific factors  Academic Article
• The CHADS2 score for stroke risk stratification in atrial fibrillation – friend or foe?  Academic Article
• The Cost-Effectiveness of Extended-Duration Antithrombotic Prophylaxis After Total Hip Arthroplasty  Academic Article
• The Duration of Oral Anticoagulant Therapy after a Second Episode of Venous Thromboembolism  Academic Article
• The Duration of Oral Anticoagulation after Deep Vein Thrombosis  Academic Article
• The Effect of Very-low-dose Warfarin on Markers of Hypercoagulation in Metastatic Breast Cancer: Results from a Randomized Trial  Academic Article
• The Effects of Low-intensity Warfarin on Coagulation Activation in Patients with Antiphospholipid Antibodies and Systemic Lupus Erythematosus  Academic Article
• The King is Dead (Warfarin): Direct Thrombin and Factor Xa Inhibitors: The Next Diadochian War?  Academic Article
• The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V—Special Situations  Academic Article
• The Pathogenesis of Venous Limb Gangrene Associated with Heparin-Induced Thrombocytopenia  Academic Article
• The Pharmacology and Management of the Vitamin K Antagonists  Academic Article
• The Risk Factors for Thromboembolism in Nonvalvular Atrial Fibrillation and CHADS2 Scoring in Japan  Academic Article
• The Risk of Hemorrhage Among Patients With Warfarin-Associated Coagulopathy  Academic Article
• The Warfarin and Antiplatelet Therapy in Heart Failure Trial (WATCH): rationale, design, and baseline patient characteristics  Academic Article
• The anticoagulation choices of internal medicine residents for stroke prevention in non-valvular atrial fibrillation  Academic Article
• The beginning of the end of warfarin?  Academic Article
• The clinical impact of bleeding during oral anticoagulant therapy  Academic Article
• The effect of low-dose oral vitamin K supplementation on INR stability in patients receiving warfarin  Academic Article
• The effects of oral anticoagulants in patients with peripheral arterial disease: Rationale, design, and baseline characteristics of the Warfarin and Antiplatelet Vascular Evaluation (WAVE) trial, including a meta-analysis of trials  Academic Article
• The hazards of interrupting anticoagulation therapy in atrial fibrillation  Academic Article
• The international normalized ratio. A guide to understanding and correcting its problems  Academic Article
• The management of anticoagulated patients requiring dental extraction: a cross‐sectional survey of oral and maxillofacial surgeons and hematologists  Academic Article
• The management of congestive heart failure  Academic Article
• The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study  Academic Article
• The organization to assess strategies for ischemic syndromes (OASIS) pilot study: evaluation of acute and long-term therapies for patients with acute coronary syndromes without ST elevation  Academic Article
• The relative importance of barriers to the prescription of warfarin for nonvalvular atrial fibrillation.  Academic Article
• The safety of oral anticoagulants registry (SOAR): A national, ED-based study of the evaluation and management of bleeding and bleeding concerns due to the use of oral anticoagulants  Academic Article
• Thoracoscopic Left Atrial Appendage Occlusion for Stroke Prevention Compared With Long-Term Warfarin Therapy in Patients With Nonvalvular Atrial Fibrillation  Academic Article
• Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis  Academic Article
• Thromboembolic Consequences of Subtherapeutic Anticoagulation in Patients Stabilized on Warfarin Therapy: The Low INR Study  Conference Paper
• Thromboembolic Events in Users of Warfarin Treated with Different Skeletal Muscle Relaxants  Academic Article
• Thromboembolic prophylaxis in 3575 hospitalized patients with atrial fibrillation. The Clinical Quality Improvement Network (CQIN) Investigators.  Academic Article
• Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy  Academic Article
• Thromboprophylaxis practice patterns in two Western Australian teaching hospitals.  Academic Article
• Thrombosis and embolism in pediatric cardiomyopathy  Academic Article
• Thrombosis in Children  Academic Article
• Thrombotic Complications and Thromboprophylaxis Across All Three Stages of Single Ventricle Heart Palliation  Academic Article
• Thrombotic Complications of Neonates and Children with Congenital Nephrotic Syndrome  Academic Article
• Time in therapeutic range: Warfarin anticoagulation for atrial fibrillation in a community-based practice.  Academic Article
• Timing of coronary stent thrombosis in patients treated with ticlopidine and aspirin  Academic Article
• Transient Global Amnesia as the Presenting Feature of Heparin-Induced Thrombocytopenia  Academic Article
• Transition from apixaban to warfarin—addressing excess stroke, systemic embolism, and major bleeding  Academic Article
• Treatment and prophylaxis of venous thromboembolism during pregnancy  Academic Article
• Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis  Academic Article
• Treatment of Deep-Vein Thrombosis  Academic Article
• Treatment of Warfarin-Associated Coagulopathy  Academic Article
• Treatment of acute pulmonary embolism with dabigatran versus warfarin  Academic Article
• Treatment of venous thromboembolism with dabigatran  Academic Article
• Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial  Academic Article
• Treatment of warfarin-associated coagulopathy with vitamin K  Academic Article
• Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer  Academic Article
• Trends in Prescribing Oral Anticoagulants in Canada, 2008–2014  Academic Article
• Twelve‐month outcomes and predictors of very stable INR control in prevalent warfarin users  Academic Article
• Unanswered questions in venous thromboembolism  Academic Article
• Uncertainty in the minimum event risk to justify treatment was evaluated  Academic Article
• Underuse of evidence-based warfarin dosing methods for atrial fibrillation patients  Academic Article
• Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis  Academic Article
• Upper gastrointestinal haemorrhage following cardiac surgery  Academic Article
• Urgent procedures or surgeries in patients receiving oral anticoagulants: a systematic literature review  Academic Article
• Urgent surgery or procedures in patients taking dabigatran or warfarin: Analysis of perioperative outcomes from the RE-LY trial  Academic Article
• Use of Warfarin in People with Low Glomerular Filtration Rate or on Dialysis  Academic Article
• Use of antithrombotic agents during pregnancy.  Academic Article
• Use of warfarin (coumarin).  Academic Article
• Validation of a patient decision aid for choosing between dabigatran and warfarin for atrial fibrillation.  Academic Article
• Values and preferences for oral antithrombotic therapy in patients with atrial fibrillation: physician and patient perspectives  Academic Article
• Values and preferences in oral anticoagulation in patients with atrial fibrillation, physicians' and patients' perspectives: protocol for a two-phase study  Academic Article
• Variation in Warfarin Dose Adjustment Practice Is Responsible for Differences in the Quality of Anticoagulation Control Between Centers and Countries  Academic Article
• Venous Limb Gangrene during Warfarin Treatment of Cancer-Associated Deep Venous Thrombosis  Academic Article
• Venous Thromboembolism and Cancer  Academic Article
• Venous Thromboembolism in Older Adults: A Community-based Study  Academic Article
• Venous limb gangrene and fatal hemorrhage: Adverse consequences of hit “overdiagnosis” in a patient with antiphospholipid syndrome  Academic Article
• Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin-induced thrombocytopenia  Academic Article
• Venous thromboembolism in heparin-induced thrombocytopenia  Academic Article
• Venous thromboembolism in pregnancy: diagnosis, management and prevention  Academic Article
• Venous thromboembolism management: where do novel anticoagulants fit?  Academic Article
• Very low-dose warfarin prophylaxis to prevent thromboembolism in women with metastatic breast cancer receiving chemotherapy: an economic evaluation.  Academic Article
• Vitamin K antagonist-experienced patients with a history of stroke/transient ischaemic attack who switched from warfarin to dabigatran increased their rate of recurrent stroke/transient ischaemic attack compared with those on warfarin  Academic Article
• Vitamin K antagonists and cancer: rebuttal  Academic Article
• Vitamin K in anticoagulation therapy  Academic Article
• Vitamin K versus warfarin interruption alone in patients without bleeding and an international normalized ratio > 10  Academic Article
• Warfarin After Bioprosthetic Aortic Valve Implantation  Academic Article
• Warfarin Cessation Before Cardiopulmonary Bypass: Lessons Learned from a Randomized Controlled Trial of Oral Vitamin K  Academic Article
• Warfarin Dose Assessment Every 4 Weeks Versus Every 12 Weeks in Patients With Stable International Normalized Ratios  Academic Article
• Warfarin Interactions With Antibiotics in the Ambulatory Care Setting  Academic Article
• Warfarin Is the Preferred Therapy for Patients With Thrombotic APS  Academic Article
• Warfarin Maintenance Dosing Patterns in Clinical Practice  Academic Article
• Warfarin Prophylaxis in the Antiphospholipid Antibody Syndrome  Academic Article
• Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis  Academic Article
• Warfarin Therapy and Risk of Hip Fracture Among Elderly Patients  Academic Article
• Warfarin Therapy for Atrial Fibrillation: The Patient's Preference Is Important  Academic Article
• Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial  Academic Article
• Warfarin and Aspirin after Heart-Valve Replacement  Academic Article
• Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm  Academic Article
• Warfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility  Academic Article
• Warfarin and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation Receiving Dialysis: A Systematic Review and Meta-analysis  Academic Article
• Warfarin in Heart Failure  Academic Article
• Warfarin resumption following anticoagulant-associated intracranial hemorrhage: A systematic review and meta-analysis  Academic Article
• Warfarin use in atrial fibrillation: A random sample survey of family physician beliefs and preferences.  Academic Article
• Warfarin use in hemodialysis patients with atrial fibrillation: decisions based on uncertainty  Academic Article
• Warfarin-Induced Skin Necrosis in 2 Patients with Protein S Deficiency: Successful Reinstatement of Warfarin Therapy  Academic Article
• Warfarin-associated multiple digital necrosis complicating heparin-induced thrombocytopenia and Raynaud's phenomenon after aortic valve replacement for adenocarcinoma-associated thrombotic endocarditis  Academic Article
• Warfarin-induced venous limb ischemia/gangrene complicating cancer: a novel and clinically distinct syndrome  Academic Article
• What Influences the Cost Effectiveness of Dabigatran versus Warfarin for Stroke Prevention in Atrial Fibrillation: A Systematic Review  Academic Article
• What Is the Evidence for the Off-label Use of Recombinant Factor VIIa (rFVIIa) in the Acute Reversal of Warfarin?  Academic Article
• When guidelines collide  Academic Article
• When should an effective treatment be used?  Academic Article
• Which Risk Factors Are More Associated With Ischemic Stroke Than Intracerebral Hemorrhage in Patients With Atrial Fibrillation?  Academic Article
• Why Do Patients With Atrial Fibrillation Not Receive Warfarin?  Academic Article
• Withdrawal of warfarin after deep vein thrombosis  Academic Article
• Work-related effort thrombosis in a millwright: A case report  Academic Article
• Ximelagatran or Warfarin for Stroke Prevention in Patients With Atrial Fibrillation?  Academic Article
• Ximelagatran or warfarin in atrial fibrillation?  Academic Article
• [Continued oral anticoagulation during cardiac pacing: the BRUISE CONTROL study].  Academic Article
• [Prothromplex in stead of Beriplex P/N as acute antidote against warfarin].  Academic Article
• [There is evidence for prolonged low-intensity warfarin therapy after venous thrombosis].  Academic Article
• [Venous thromboembolism, warfarin and cancer--a well-known connection].  Academic Article